000 01456 a2200421 4500
005 20250517095317.0
264 0 _c20170510
008 201705s 0 0 eng d
022 _a1744-8328
024 7 _a10.1080/14737140.2016.1192468
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCiccarese, Chiara
245 0 0 _aThe safety and efficacy of enzalutamide in the treatment of advanced prostate cancer.
_h[electronic resource]
260 _bExpert review of anticancer therapy
_cJul 2016
300 _a681-96 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAndrogen Antagonists
_xadverse effects
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aBenzamides
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNitriles
650 0 4 _aPhenylthiohydantoin
_xadverse effects
650 0 4 _aProstatic Neoplasms, Castration-Resistant
_xdrug therapy
650 0 4 _aQuality of Life
650 0 4 _aSurvival Rate
700 1 _aNobili, Elisabetta
700 1 _aGrilli, Donatella
700 1 _aCasolari, Laura
700 1 _aRihawi, Karim
700 1 _aGelsomino, Francesco
700 1 _aTortora, Giampaolo
700 1 _aMassari, Francesco
773 0 _tExpert review of anticancer therapy
_gvol. 16
_gno. 7
_gp. 681-96
856 4 0 _uhttps://doi.org/10.1080/14737140.2016.1192468
_zAvailable from publisher's website
999 _c26046626
_d26046626